COMPARATIVE INVITRO EVALUATION OF BMY-28142, A NEW BROAD-SPECTRUM CEPHALOSPORIN, VERSUS OTHER BETA-LACTAMS AGAINST MULTIRESISTANT GRAM-NEGATIVE ISOLATES

被引：0

|

作者：

GIAMARELLOU, H

SAHIN, A

CHRYSSOULI, Z

机构：

来源：

DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 1987年 / 13卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：149 / 153

页数：5

相关论文

共 39 条

[31] COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH AMPICILLIN AND BROAD-SPECTRUM PENICILLINS AGAINST DEFINED BETA-LACTAMASE-PRODUCING AEROBIC GRAM-NEGATIVE BACILLI
JACOBS, MR
ARONOFF, SC
JOHENNING, S
SHLAES, DM
YAMABE, S
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) : 980 - 985
[32] INVITRO ACTIVITY OF CEFBUPERAZONE COMPARED WITH THAT OF OTHER NEW BETA-LACTAM AGENTS AGAINST ANAEROBIC GRAM-NEGATIVE BACILLI AND CONTRIBUTION OF BETA-LACTAMASE TO RESISTANCE
DELBENE, VE
CAREK, PJ
TWITTY, JA
BURKEY, LJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) : 817 - 820
[33] COMPARATIVE INVITRO ACTIVITY OF THE NEW QUINOLONE SPARFLOXACIN (CI-978, AT-4140) AGAINST NOSOCOMIAL GRAM-NEGATIVE BLOOD-STREAM ISOLATES
DOEBBELING, BN
PFALLER, MA
BALE, MJ
WENZEL, RP
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (04) : 298 - 301
[34] COMPARATIVE INVITRO ANTIBACTERIAL ACTIVITY OF A NEW MONOBACTAM - CARUMONAM (RO 17-2301, AMA-1080) AGAINST HOSPITAL ISOLATES OF BETA-LACTAM RESISTANT GRAM-NEGATIVE BACILLI
LENOC, P
CROIZE, J
LENOC, D
PATHOLOGIE BIOLOGIE, 1987, 35 (05): : 451 - 456
[35] BMY-28100, A NEW ORAL CEPHALOSPORIN - ANTIMICROBIAL ACTIVITY AGAINST NEARLY 7,000 RECENT CLINICAL ISOLATES, COMPARATIVE POTENCY WITH OTHER ORAL-AGENTS, AND ACTIVITY AGAINST BETA-LACTAMASE PRODUCING ISOLATES
JONES, RN
BARRY, AL
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1988, 9 (01) : 11 - 26
[36] COMPARATIVE INVITRO ACTIVITY OF CARUMONAM (RO-17-2301/AMA-1080), A NEW MONOBACTAM, AND CEFTRIAXONE AGAINST AEROBIC OR FACULTATIVE GRAM-NEGATIVE ISOLATES
BARCLAY, CA
IRIBARREN, MA
GOLDBERG, M
TRABALLI, CA
CASELLAS, JM
CHEMOTHERAPY, 1987, 33 (03) : 165 - 171
[37] INVITRO EVALUATION OF S-25930 AND S-25932, 2 NEW QUINOLONES, AGAINST AEROBIC GRAM-NEGATIVE ISOLATES FROM CANCER-PATIENTS
ROLSTON, KVI
HO, DH
LEBLANC, B
BODEY, GP
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) : 102 - 103
[38] INVITRO ACTIVITY OF A NEW BROAD-SPECTRUM, BETA-LACTAMASE-STABLE ORAL CEPHALOSPORIN, CEFIXIME, IN COMPARISON WITH OTHER DRUGS, AGAINST HAEMOPHILUS-INFLUENZAE, HAEMOPHILUS-PARAINFLUENZAE, MORAXELLA-CATARRHALIS AND STREPTOCOCCUS-PNEUMONIAE
STEFANI, S
PELLEGRINO, MB
DAMICO, G
PRIVITERA, A
PRIVITERA, O
MACCARRONE, G
RUSSO, G
NICOLETTI, G
CHEMOTHERAPY, 1992, 38 (01) : 36 - 45
[39] Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric Gram-negative Bacilli: Occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes
Jones, RN
Pfaller, MA
Marshall, SA
Hollis, RJ
Wilke, WW
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (03) : 187 - 192

← 1 2 3 4 →